Protara Therapeutics, Inc. Letters of Credit Outstanding, Amount
Protara Therapeutics, Inc. (TARA) had Letters of Credit Outstanding, Amount of $0 as of 2019-12-31, per its 10-K filed 2020-03-20.
Discontinued › Notes
us-gaap:LettersOfCreditOutstandingAmount · last filed 2020-03-20
- 2019-12-31: Letters of Credit Outstanding, Amount $0.00.
- 2019-09-30: Letters of Credit Outstanding, Amount $22.00K.
- 2019-06-30: Letters of Credit Outstanding, Amount $22.00K.
- 2019-03-31: Letters of Credit Outstanding, Amount $22.00K.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-20 |
| 2019-09-30 | $22.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $22.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $22.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $22.00K 10-K · filed 2020-03-20 |
| 2018-09-30 | $22.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $22.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $22.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $22.00K 10-K · filed 2019-03-13 |
| 2017-09-30 | $22.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $14.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $14.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $14.00K 10-K · filed 2018-03-14 |
| 2016-09-30 | $14.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $14.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $14.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $14.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $14.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $14.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $14.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $38.00K 10-K · filed 2016-03-14 |
| 2013-12-31 | $38.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |